Related Experiment Video
Updated: Jun 8, 2026
08:13
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Estimation of the ischemic penumbra based on CT perfusion a pilot study
Zhihua Sun1, Xuejun Zhang, Yunting Zhang
1Department of Radiology, Tianjin Medical University General Hospital, Heping District, the People's Republic of China.
Academic Radiology
|October 16, 2010
Summary
Computed tomography perfusion (CTP) using relative cerebral blood flow (rCBF) offers a more accurate method for estimating the ischemic penumbra (IP) size compared to MRI. This CTP method provides better insights into early ischemic evolution.
Area of Science:
- Neuroscience
- Radiology
- Medical Imaging
Background:
- The ischemic penumbra (IP) is crucial for thrombolytic therapy targeting.
- Magnetic resonance imaging (MRI) methods for estimating IP have faced accuracy challenges.
- Accurate IP quantification is vital for effective stroke treatment.
Purpose of the Study:
- To develop and validate a computed tomography perfusion (CTP) based method for calculating ischemic penumbra size.
- To compare the accuracy of CTP and MRI in estimating IP.
- To analyze the early dynamic evolution of IP.
Main Methods:
- Utilized a middle cerebral artery occlusion (MCAO) monkey model.
- Employed receiver operating characteristic (ROC) curve analysis to determine optimal CTP parameters for IP estimation.
- Compared dynamic IP size estimations between CTP and MRI methods.
Main Results:
- Relative cerebral blood flow (rCBF) on CTP demonstrated high sensitivity (83.3%) and specificity (98.5%) for IP estimation.
- An optimal rCBF cutoff threshold of 0.203 was identified.
- CTP-rCBF estimated larger IP sizes than MRI in the early MCAO stage (first 15 hours), with the trend reversing later.
Conclusions:
- The CTP-rCBF method is proposed as a more accurate approach for IP estimation.
- This method may overcome MRI's underestimation in early ischemia and overestimation in later stages.
- Further validation through experimental and clinical studies is recommended.
